NCT02856542
Completed
Not Applicable
Real-life Evaluation of an Applicator, as a New Mode of Administration of Daivobet® Gel, on Adherence to Treatment and SAtisfaction of Patients With PSOriasis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Plaque Psoriasis
- Sponsor
- LEO Pharma
- Enrollment
- 1560
- Locations
- 1
- Primary Endpoint
- Morisky Medication Adherence Scale-8
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This study aims to describe the patient population being treated and evaluate their treatment adherence and treatment outcomes during treatment of scalp psoriasis with Daivobet® gel Applicator for 4 weeks.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age ≥ 18 years
- •Dermatologist or general practitioner has decided to initiate treatment with Daivobet® gel Applicator
Exclusion Criteria
- •Indication not within the approved labelling in France
- •Contraindication for treatment with calcipotriol or betamethasone dipropionate
- •Informed consent to participate in the study has not been obtained
Outcomes
Primary Outcomes
Morisky Medication Adherence Scale-8
Time Frame: 4 weeks
Degree of adherence to prescribed treatment
Secondary Outcomes
- Patient opinion on Applicator usability(4 weeks)
- Patient overall satisfaction(4 weeks)
- Patient Global Impression of Improvement(4 weeks)
- Investigator's opinion on the properties of the Applicator(Baseline)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar DisorderBipolar DisorderNCT01455961AstraZeneca16,000
Withdrawn
Not Applicable
A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myelodysplastic SyndromesMyelodysplastic Syndromes (MDS)NCT06581055Bristol-Myers Squibb86
Completed
Not Applicable
Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceChronic Obstructive Pulmonary DiseaseNCT02187926AstraZeneca2,577
Completed
Not Applicable
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment AdherenceBreast CancerNCT01081509AstraZeneca1,077
Completed
Not Applicable
The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)Sleep Disordered BreathingObstructive Sleep ApneaNCT03725839Fisher and Paykel Healthcare33